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Abstract
Large fractions of eukaryotic genomes contain repetitive sequences of which the vast majority is derived from transposable
elements (TEs). In order to inactivate those potentially harmful elements, host organisms silence TEs via methylation of
transposon DNA and packaging into chromatin associated with repressive histone marks. The contribution of individual
histone modifications in this process is not completely resolved. Therefore, we aimed to define the role of reversible histone
acetylation, a modification commonly associated with transcriptional activity, in transcriptional regulation of murine TEs. We
surveyed histone acetylation patterns and expression levels of ten different murine TEs in mouse fibroblasts with altered
histone acetylation levels, which was achieved via chemical HDAC inhibition with trichostatin A (TSA), or genetic
inactivation of the major deacetylase HDAC1. We found that one LTR retrotransposon family encompassing virus-like 30S
elements (VL30) showed significant histone H3 hyperacetylation and strong transcriptional activation in response to TSA
treatment. Analysis of VL30 transcripts revealed that increased VL30 transcription is due to enhanced expression of a limited
number of genomic elements, with one locus being particularly responsive to HDAC inhibition. Importantly, transcriptional
induction of VL30 was entirely dependent on the activation of MAP kinase pathways, resulting in serine 10 phosphorylation
at histone H3. Stimulation of MAP kinase cascades together with HDAC inhibition led to simultaneous phosphorylation and
acetylation (phosphoacetylation) of histone H3 at the VL30 regulatory region. The presence of the phosphoacetylation mark
at VL30 LTRs was linked with full transcriptional activation of the mobile element. Our data indicate that the activity of
different TEs is controlled by distinct chromatin modifications. We show that activation of a specific mobile element is linked
to a dual epigenetic mark and propose a model whereby phosphoacetylation of histone H3 is crucial for full transcriptional
activation of VL30 elements.
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Introduction
Our present view on transcriptional regulation has substantially
advanced in recent decades. The classical model, that the presence of
promoter sequences and the availability of transcription factors
determine the expression status of corresponding genes, has been
extended to a model, in which the accessibility of the DNA is central
to transcriptional control. In eukaryotes, DNA is packed and
compacted into chromatin with the nucleosome consisting of DNA
and histone proteins as the basic unit. The degree of compaction –
either into inaccessible heterochromatin or open euchromatin – has
major implications for the transcriptional potential of associated
DNA. A way to regulate chromatin accessibility is the posttransla-
tional chemical modification of histone proteins. It can alter
chromatin structure and switchgenes from a transcriptional repressed
to an active state and vice versa [1].
The best-studied histone modification is the acetylation of N-
terminal lysine residues, which correlates with open chromatin and
active gene transcription. In contrast, histone deacetylation is
linked to gene silencing and histone deacetylases (HDACs) are
considered as transcriptional co-repressors [2]. Only recently, a
more general role of histone deacetylation during transcriptional
regulation is emerging [3]. The use of chemical HDAC inhibitors
and knock out/down technologies resulted in the identification of
an increasing number of target genes controlled by histone
acetylation in different cellular contexts [4–6]. Based on sequence
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classes, of which class I enzymes seem to fulfil more basic cellular
functions whereas class II enzymes are thought to play specialised
cell-type specific roles. HDACs are often found to interact with
proteins important for stable gene silencing via DNA methylation
and constitution of heterochromatin, but also with transcriptional
regulators mediating only transient repression. Crosstalk between
histone acetylation and other epigenetic marks is an important
feature of HDAC function [7]. Hence, HDACs are central
components of multiple silencing complexes containing additional
enzymatic activities such as DNA and histone methylation.
Recent annotation of multiple complete genomes has revealed
that a large fraction of eukaryotic genomes consists of repetitive
sequences, mainly derived from transposable elements (TEs) [8,9].
Most of those sequences are remnants of once active TEs now
incapable of transposition because of their host-mediated inacti-
vation followed by subsequent functional erosion and the
accumulation of mutations and deletions. However, some elements
remain intact and constitute a constant threat to the integrity of
the host genome. Potentially functional elements can act as
insertion-mutagens via targeting protein coding genes or causing
chromosome breakage. Even transpositionally inactive TEs have
the potential to trigger illegitimate recombination and genome
rearrangement, or to influence neighbouring genes by causing
alternative splicing, premature termination, and modulating gene
expression patterns [10,11]. Recent estimations suggest that TEs
provoke around 0.1% (in humans) or 10–12% (in mice) of all
spontaneous germ line mutations, and an increasing number of
reports document the contribution of somatic transposon activity
to pathological situations [11–13]. Consequently, organisms were
challenged to evolve multiple lines of defence to restrict TE
activity, targeting crucial steps in their life cycle [11,14]. One of
the most efficient host-directed strategies is to block TE
transcription. This is achieved applying epigenetic mechanisms
such as DNA methylation, modification of chromatin structure,
and the action of small RNAs [13,15–19]. Different subclasses of
small RNAs (siRNAs, rasiRNAs and piRNAs) seem to guide and
target the silencing machinery, while chromatin modifiers and
DNA methyltransferases (DNMTs) accomplish the transformation
into a heterochromatic, transcriptionally silent state [20]. Numer-
ous proteins, involved in the establishment, maintenance and read-
out of DNA methylation and chromatin modification patterns, are
crucial for TE silencing in germline and somatic cells [13].
However, the exact contribution of DNA methylation, chromatin
remodelling, modification of histones and their interplay has not
been completely resolved. Analysis in several model organisms
revealed that the different silencing-mechanisms are of varying
importance depending on the host organism. Some (e.g. yeast and
Drosophila) lack an efficient DNA methylation machinery and
therefore depend on alternative silencing pathways, while others
(e.g. mammals and plants) widely use DNA methylation in concert
with other mechanisms to silence TEs [18,21].
Despite the tight collaboration of multiple silencing layers,
numerous TEs maintain their capacity to escape host-mediated
silencing under certain conditions. Different types of internal and
external stimuli are able to trigger TE activity in a wide range of
organisms. Many of those stimuli can be subsumed as cellular
stress and the correlation between TE activity and stress has been
in the focus of interest for several decades [22,23]. Recent
examples of mammalian TEs, showing increased transcriptional
activity upon external stimuli, include members of all major TE
orders: SINEs [24,25], LINEs [26], and LTR elements [27].
To better understand the role of histone acetylation in
transcriptional regulation of TEs in mammalian somatic cells,
we monitored the expression of selected, potentially active TEs in
mouse fibroblasts with impaired histone deacetylase capacity. In
our present study we found that chemical inhibition of class I and
II HDACs, but not genetic inactivation of HDAC1 alone, resulted
in local hyperacetylation and expression of a defined subset of
VL30 LTR retrotransposable elements. Furthermore, we show
that not only histone acetylation, but histone phosphorylation in
concert with acetylation (phosphoacetylation) was triggering
transcriptional induction of VL30 elements. We suggest a model,
in which external stress signals cause the activation of MAP kinase
pathways, ultimately leading to the phosphoacetylation of histones
and efficient transcription of VL30 elements.
Results
To assess the epigenetic control of TEs with respect to histone
acetylation, we treated mouse 3T3 fibroblasts with the deacetylase
inhibitor trichostatin A (TSA), a compound efficiently inhibiting
class I and II HDACs and the DNA methyltransferase inhibitor
59-Aza-29-deoxycytidine (Aza-dC). Pilot studies had shown that
loss of the class I deacetylase HDAC1 in fibroblasts resulted in
significantly reduced total cellular HDAC activity, suggesting a
prominent role of this enzyme in histone acetylation in this cell
type (data not shown). Therefore we also included immortalised
HDAC1-deficient fibroblasts (HDAC1
2/2) in this study.
Effects of HDAC1 depletion, TSA, and Aza-dC treatment
on mouse fibroblasts
To confirm that our experimental setup indeed perturbed
epigenetic states in mouse fibroblasts, we performed the following
experiments: firstly, we monitored the expression levels of proteins
targeted by chemical or genetic inhibition. Protein expression
levels of the class I deacetylases HDAC1, HDAC2, HDAC3 and
the maintenance DNA methyltransferase DNMT1 were surveyed
via Western blot. As shown in Figure 1A, loss of HDAC1 in
immortalized fibroblasts led to upregulation of HDAC2, its closest
Author Summary
The majority of genomic sequences in higher eukaryotes
do not contain protein coding genes. Large fractions are
covered by repetitive sequences, many of which are
derived from transposable elements (TEs). These selfish
genes, only containing sequences necessary for self-
propagation, can multiply and change their location
within the genome, threatening host genome integrity
and provoking mutational bursts. Therefore host organ-
isms have evolved a diverse repertoire of defence
mechanisms to counteract and silence these genomic
parasites. One way is to package DNA sequences
containing TEs into transcriptionally inert heterochromatin,
which is partly achieved via chemical modification of the
packaging proteins associated with DNA, the histones. To
better understand the contribution of histone acetylation
in the activation of TEs, we treated mouse fibroblasts with
a specific histone deacetylase inhibitor. By monitoring the
expression of ten different types of murine mobile
elements, we identified a defined subset of VL30
transposons specifically reactivated upon increased his-
tone acetylation. Importantly, phosphorylation of histone
H3, a modification that is triggered by stress, is required for
acetylation-dependent activation of VL30 elements. We
present a model where concomitant histone phosphory-
lation and acetylation cooperate in the transcriptional
induction of VL30 elements.
Phosphoacetylation of VL30 Elements
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effects caused by the loss of HDAC1, but still total cellular HDAC
activity was diminished by about 30% in HDAC1
2/2 compared
to HDAC1
+/+ cell lines (data not shown), demonstrating an
important enzymatic function of HDAC1 in fibroblasts. In our
experimental setup TSA treatment for 24h did not influence
expression of HDAC1, HDAC2 or HDAC3, whereas DNMT1
levels were slightly decreased. A reduction of DNMT1 levels after
histone deacetylase inhibitor treatment has been previously
reported [28,29]. Aza-dC treatment resulted in slightly reduced
amounts of DNMT1, consistent with earlier reports showing that
Aza-dC can trap DNMT1 by covalently linking the enzyme to
DNA [30] or lead to proteasomal degradation of the DNMT1
protein [31]. Protein expression of HDAC1, HDAC2 and
HDAC3 remained unaffected.
Next, we evaluated effects on the biological targets of HDACs and
DNMT1, i.e. the acetylation states of histones and CpG methylation
levelsof DNA. To examine CpG methylation levels at defined targets
we employed the MS-SNuPE technique [32]. We quantified DNA
methylation levels of three CpG sites within the regulatory LTR
region of an IAP retrotransposons, highly methylated in somatic cells
[33]. Whereas neither loss of HDAC1, nor chemical inhibition of
HDACs with TSA for 24h affected levels of DNA methylation, Aza-
dC treatment for 24h severely reduced DNA methylation of the IAP
LTR region to 50% (Figure 1B).
Furthermore, we analysed histone acetylation levels in wildtype
fibroblasts, either untreated (HDAC1
+/+) or treated with TSA and
Aza-dC and HDAC1-deficient cells (HDAC1
2/2). To that end we
extracted histones and performed Western blot analyses using
antibodies recognising acetylated histones. Previous reports had
shown that in murine embryonic stem cells genetic inactivation of
Hdac1wasaccompanied byhyperacetylationofhistonesH3and H4,
detectable with antibodies recognising acetylated histone H3 (H3ac)
and acetylated histone H4 proteins (H4ac) [34]. In our fibroblast
system, however, we failed to detect global hyperacetylation of
histones in HDAC1
2/2 cells as compared to HDAC1
+/+ cells using
such H3ac or H4ac antibodies (Figure 1C); only when we probed the
blots with antibodies specifically recognising the acetylation state of
individual lysine residues, we detected weak hyperacetylation
occurring at defined residues (data not shown). In contrast to this
limited site-specific response, inhibition of all class I and II HDACs
with TSA led to a robust and global hyperacetylation detectable with
H3ac and H4ac antibodies. Finally, interfering with DNA methyl-
ation by Aza-dC treatment moderately enhanced global H3 and H4
acetylation levels (Figure 1C).
Histone acetylation of transposon-associated chromatin
After defining global effects of HDAC and DNMT inhibition in
our cell system, we moved on to specifically address the role of
histone acetylation in the regulation of TEs. We analysed the
acetylation state of chromatin associated with defined TEs in
wildtype fibroblasts without treatment (HDAC1
+/+), or treated
either with TSA or Aza-dC, and HDAC1-deficient fibroblasts
(HDAC1
2/2). To monitor their acetylation status, we performed
chromatin-immunoprecipitation (ChIP) experiments with H3ac
and H4ac antibodies. Furthermore, we included antibodies
recognising the C-terminal part of histone H3 to survey
nucleosome occupancy and unspecific rabbit IgGs to control the
specificity of immunoprecipitation reactions. Quantitative Real-
Time PCR analyses allowed the quantification of H3 and H4
acetylation levels associated with a representative selection of ten
murine TEs, including a DNA transposon (Tigger), non-LTR
retrotransposons (LINEs, SINEs), and LTR retrotransposons
(VL30, IAP, ETn, MERVL, MT, ORR1) (Table 1). We chose
LINEs and SINEs, because they constitute the majority of murine
TEs and populate the genome in more than 660,000 and 1.5
million copies, respectively. LTR elements are less abundant, but
harbour the most active TEs within the mouse lineage; MERVL,
MT and ORR1 elements are expressed during early embryogen-
esis [35] and VL30, IAP and ETn elements have been responsible
for a number of germ line transposition events [12]. The
transposon Tigger was included as representative of the class of
DNA elements, which is functionally extinct in vertebrates. As
shown in Figure 2A (upper panel), loss of HDAC1 did not
influence histone H3 acetylation at any transposon type analysed
as compared to wildtype cells. In contrast, TSA treatment was
sufficient to specifically enhance H3 acetylation at SINE B1 and
B2 elements and VL30 LTR elements, the latter ones near the
promoter as well as throughout the body of the element. Histone
Figure 1. Effects of HDAC1 depletion, TSA treatment, and Aza-
dC treatment on DNA–methylation and histone acetylation
patterns in mouse fibroblasts. Mouse wildtype fibroblasts were left
untreated (HDAC1
+/+) or treated with TSA (166nM; 24h for (A) and (B);
3h for (C)) or Aza-dC (1mM for 24h; 24h recovery). In addition untreated
HDAC1 deficient fibroblasts (HDAC1
2/2) were included in these
experiments. (A) Western blot analysis of chromatin modifying
enzymes. Proteins were extracted, separated by SDS-PAGE and analysed
with antibodies specific for HDAC1, HDAC2 and DNMT1. Equal loading
was controlled with an antibody raised against b-ACTIN. (B) DNA
methylation of IAP retrotransposons in HDAC1
+/+ (black bars) and
HDAC1
2/2 (grey bars) fibroblasts. Both cell lines were treated with TSA
or Aza-dC as described above. Average DNA methylation levels of three
CpG sites within the LTR were determined employing the Ms-SNuPE
technique. (C) Analysis of histone acetylation patterns. Histones were
extracted and analysed on Western blots using H3ac and H4ac specific
antibodies. Equal loading was monitored with an antibody recognising
the C-terminus of histone H3 (c-H3).
doi:10.1371/journal.pgen.1000927.g001
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in a subsequent series of experiments. Again, loss of HDAC1 did
not alter histone acetylation at tested transposons, but TSA-
induced inhibition of all class I and II HDACs led to increased H4
acetylation at all repeat families investigated (Figure 2A; lower
panel). Thus, TSA treatment exhibited differential effects on
histone H3 and histone H4 acetylation of TEs. Whereas H3
histones were found hyperacetylated at specific elements only, H4
hyperacetylation occurred as a global response. Interestingly, the
elements hyperacetylated at H3 upon TSA treatment, SINEs and
VL30, also showed highest enrichment of H4 acetylation
compared to other TEs.
Next, we analysed histone acetylation levels upon loss of DNA
methylation. Incubation of cells with Aza-dC increased H3
acetylation at SINE B1 and VL30 elements (Figure 2B, upper
panel), although to a lesser extent than TSA. Furthermore, IAP
element promoter sequences exhibited slightly increased H3
acetylation levels in response to Aza-dC. Finally, Aza-dC
treatment resulted in elevated H4 acetylation levels of SINEs,
VL30 and IAP elements (Figure 2B; lower panel).
Transcriptional activation of transposable elements
Since hyperacetylation of histones in general correlates with
transcriptional activation, we tested whether increased histone
acetylation levels were mirrored by changes in transcriptional
activity of TEs. Therefore we monitored mRNA levels of the ten
mouse transposons, listed in Table 1, in untreated wildtype
fibroblasts (HDAC1
+/+), TSA or Aza-dC treated wildtype cells,
and HDAC1-deficient fibroblasts (HDAC1
2/2) by real-time PCR
analyses. We also analysed the expression of another LTR
element, MuLV, which comprises endogenous as well as
exogenous family members [36] (Figure S1). As shown in
Figure 3, upper panel and Figure S1, loss of HDAC1 did not
influence TE expression. In contrast, general HDAC inhibition via
TSA strongly increased VL30 element expression in this fibroblast
cell line (Figure 3, upper panel), as well as in other commonly used
fibroblast cell lines such as Swiss 3T3 and NIH/3T3 (data not
shown). Enhanced activity of VL30 elements correlated with
hyperacetylation of VL30 chromatin upon TSA treatment. This
suggests that modulation of histone acetylation regulates VL30
element activity. Expression of SINE B1, the second element
showing H3 and H4 hyperacetylation after TSA treatment, was
modestly increased. Besides IAPs showing a moderate two-fold
increase, all other TE candidates investigated did not exhibit
major changes in transcriptional activity. This expression pattern
mirrors the unchanged local acetylation state of histone H3, but
not the one of histone H4 acetylation, which was elevated upon
TSA treatment. Therefore, H3 acetylation of the transposons
analysed correlates with transcriptional activity, whereas H4
hyperacetylation is not sufficient to trigger transcriptional
activation.
The role of DNA methylation in transposon silencing is well
established and it has been shown earlier that loss of DNA
methylation in somatic cells correlates with VL30, IAP and MuLV
expression [37–39]. Indeed, Aza-dC treatment in fibroblasts
caused highly elevated VL30, IAP and MuLV mRNA levels, but
had no effect on other TEs tested (Figure 3, lower panel and
Figure S1). However, it was surprising that the majority of murine
elements tested could not be reactivated with Aza-dC. This finding
suggests that those transposons are not permissive for transcrip-
tional activation in our fibroblast system, either because they lack
regulatory features necessary for efficient transcriptional activation
or additional mechanisms contribute to their silencing [40]. ChIP
analyses of TE-associated chromatin showed that two elements
that were highly expressed upon Aza-dC treatment (VL30 and
IAP elements) also gained hyperacetylation after DNMT inhibi-
tion (Figure 3, lower panel). SINE B1 and SINE B2 elements, both
showing increased acetylation upon Aza-dC treatment, were not
or only modestly activated.
In summary, we could establish a correlation between the
transcriptional activity of TEs and the acetylation state of
associated chromatin. In particular histone H3 acetylation
correlated well with increased expression of certain TEs.
Furthermore, we identified VL30 elements as the single candidate
transposon efficiently regulated via acetylation of associated
chromatin.
Transposition frequency
Retrotransposition is a complex process depending on multiple
steps, each of which can be targeted by regulatory mechanisms
[11]. Alterations in RNA stability, translation efficiency, nuclear
shuttling, editing of template RNA, or integration efficiency can
have severe impact on the rate of successful transposition.
Treatment of cells with the HDAC inhibitor TSA has strong
effects on the chromatin state. Since chromatin constitutes the
substrate for the last step of transposition, i.e. integration, we tested
whether histone modification patterns might influence transposi-
tion efficiency, independent of TE transcription. Genetic screens
in yeast have uncovered numerous host factors either restricting or
enhancing transposon activity [41–45]. Strikingly, a substantial
fraction of the proteins identified has a role in chromatin biology;
for instance, SIN3 and RPD3, both major components of yeast
HDAC complexes, were found to restrict Ty1 activity and
modulate target site selection. Interestingly, SIN3 and RPD3 do
not act on the transcriptional level, as they do not alter Ty1
mRNA levels [45].
To test whether changed histone acetylation levels induced by
TSA treatment might have similar effects in mammalian cells, we
determined transposition levels of four mammalian retroelements
in untreated and TSA treated cells. To this end we took advantage
of an experimental system described earlier [46–48], in which
Table 1. Transposable elements analysed in this study.
Class Order Superfamily Family
Copy
Number
PCR Amplicon
ChIP
I LINE L1 - 599000* internal
I SINE 7SL B1 564000* promoter
I SINE tRNA B2 348000* promoter
II TIR Tc1-Mariner Tigger 24000* promoter
I LTR ERV1 VL30 150–200u promoter / internal
I LTR ERV2 IAP 1000u promoter / internal
I LTR ERV2 ETn 300–400u internal
I LTR ERV3 MERVL 200u internal
I LTR ERV3 MT 13000–50000# promoter
I LTR ERV3 ORR1 10000–38000# internal
Classification of TEs, estimated copy numbers and approximate location of the
amplicons used to survey chromatin modification states via chromatin
immunoprecipitation (ChIP). Nine out of the ten elements are retrotransposons
and propagate via a RNA intermediate (Class I), one is a DNA transposon (Class
II) [88]. The copy numbers are estimates from different references (*[9]; u[12];
#[89]). The location of the amplicon was defined as promoter specific, if both
primers were located within 6500bp of the transcriptional start site, otherwise
as internal.
doi:10.1371/journal.pgen.1000927.t001
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transgene, which gets activated only after its successful retrotrans-
position (Figure S2A). Following this approach we quantified the
transposition efficiency of murine IAP and MusD LTR retro-
transposons, and murine and human L1 elements in untreated and
TSA treated cells. In order to avoid potential interference with
endogenously transcribed IAP, MusD and L1 elements, we
performed the experiments in the human U2OS osteosarcoma
Figure 2. Histone acetylation states of transposable elements upon HDAC1 depletion, TSA treatment, and Aza-dC treatment. The
histone acetylation state of chromatin associated with defined transposable elements was determined via ChIP technique using antibodies
specifically recognising acetylated histone H3 (H3ac) and acetylated histone H4 (H4ac). Values were normalised to the nucleosome density as
determined via ChIP using antibodies recognising the C-terminal region of histone H3 (c-H3) and are given relative to the acetylation levels in
untreated fibroblasts. Control experiments employing unspecific IgG antibodies consistently led to negligible amounts of precipitated material (data
not shown). (A) Histone H3 and H4 acetylation levels of a variety of transposable elements in HDAC1
2/2 (green bars) and TSA (166nM; 24h; blue bars)
treated fibroblasts as compared to untreated HDAC1
+/+ (black bars) fibroblasts. (p) promoter region 6500bp of transcriptional start site; (int) internal
region. N=3; 6 SEM *p,0.05 (paired, one sided student’s t-test). (B) Corresponding acetylation levels of transposable elements in Azd-dC treated
fibroblasts (1mM; 24h, 24h recovery; red bars). N=5; 6 SEM *p,0.05.
doi:10.1371/journal.pgen.1000927.g002
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delivered retroelements via real-time PCR (Figure S2B). As
presented in Figure S2C, TSA treatment led to a 2- to 4-fold
increase in transposition rates, a moderate increase compared to
findings reported elsewhere, where mutation of TE restricting
factors in yeast led to an increase between 5 and several hundred
times [45]. In our system, enhanced transposition was accompa-
nied by a 2- to 3-fold increase in TE mRNA abundance. These
data suggest that TSA treatment led to enhanced expression of
marked elements, which in turn resulted in increased transposition
rates. Therefore, under our experimental conditions, inhibition of
deacetylases by TSA was not sufficient to influence TE
transposition rates independent of TE expression, suggesting
transcription as the rate-limiting factor for transposition.
Chromosomal origin and structural features of
reactivated transposable elements
In contrast to single copy genes, TEs exist in multiple copies
dispersed throughout the genome. Individual elements within a
TE family are different in respect of genomic environment,
influencing chromatin status and transcriptional potential. Fur-
thermore, transposons are under high selective pressure and
mutations mediated by host and/or transposon-intrinsic factors
lead to the generation of pools of elements with individual
sequence specificities within given TE families. Therefore, a family
of elements is a collection of similar, but heterogeneous
individuals, differing in external and internal features.
Upon external signals increased transcriptional activity could
originate from the upregulation of all TEs within a family, of a
subgroup of elements exhibiting specific features, or even a single
copy with unique intrinsic properties. In order to distinguish
between these different scenarios, we aimed to determine the
chromosomal origin of VL30 and IAP derived transcripts detected
in untreated, TSA and Aza-dC treated wildtype fibroblasts. RNA
from three independent biological samples each (untreated, TSA,
Aza-dC) was collected, reversely transcribed, and subjected to
PCR amplification. To amplify IAP derived transcripts, primers
annealing in the highly conserved gag region were used (Figure
S3A). For VL30 transcript amplification primers within the 39
UTR and 39LTR R region were chosen (Figure 4A). To exclude a
bias due to individual PCR reactions, six independent PCR
reactions for each condition were pooled, PCR products were
cloned and sequenced. As control, the same procedure was also
performed with genomic DNA as template. This approach
allowed us to amplify chromosomal copies of both candidate
elements and to estimate the diversity of IAP and VL30 elements
in our cell system.
Each sequenced clone corresponding to an individual tran-
scribed (or genomic) TE was then analysed as follows: to identify
genomic elements serving as potential sources of transcription,
sequences were blasted against the annotated murine genome
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). Genomic se-
quences exhibiting at least 98% identity to the cloned sequences
were considered to show sufficient homology to serve as potential
sources of transcription and were analysed further. If more than
one genomic sequence showed identity .98%, the sequence with
the highest E-value was chosen. That way ,90% of the cloned
sequences were assigned to distinct genomic elements (IAP: 115 of
127 clones; VL30: 111 of 122 clones). Individual characteristics,
such as chromosomal localisation and length were examined for
each element as summarised in Table S1. Next, we defined
whether the transcribed IAP and VL30 elements were derived
from multiple genomic sources, a small number of elements, or
even unique elements. Therefore, we analysed the diversity of the
identified genomic TEs, constituting bona fide sources of transposon
transcription. Following this approach, each IAP transcript could
be assigned to a different genomic element, indicating that IAP
transcripts originated from multiple loci throughout the genome
(see chromosomal origins and individual features of elements listed
in Table S1).
In untreated cells, VL30 transcripts were of heterogeneous
origin, with a broad level of sequence diversity similar to the
chromosomal VL30 elements that were amplified from genomic
DNA. In contrast, upon TSA and Aza-dC treatment, VL30
transcripts could be assigned to only four and two genomic loci,
pointing towards a limited number of VL30 elements serving as
source of expression. TSA treatment led to the accumulation of
transcripts related to the genomic loci NT_039207 4840bp on
chromosome 2 (36 of 41 sequences), NT_039341 4902bp on
chromosome 6 (3 of 41), NT_039462 5167bp on chromosome 8
(1 of 41), and NT_039649 4919bp on chromosome 17 (1 of 41).
Aza-dC treatment resulted in transcripts similar to NT_039207
4840bp on chromosome 2 (13 of 26 sequences) and NT_039341
4902bp on chromosome 6 (13 of 26) (Table S1), Alignment of
VL30 sequences directly obtained after cloning and sequencing
further showed that transcripts assigned to the genomic locus on
chromosome 2 (NT_039207 4840bp) were almost identical,
indicating a single locus as transcriptional source. In contrast,
transcripts assigned to the locus on chromosome 6 (NT_39341
4902bp) were slightly divergent, demonstrating that they
originate from a group of related VL30 elements, of which only
one copy is annotated in the published mouse genome (data not
shown).
Figure 3. Effect of TSA and Aza-dC treatment on the expression
of transposable elements. (A) Logarithmically growing fibroblasts
show increased mRNA expression levels of VL30 LTR elements when
treated with TSA. Expression levels were determined with qRT-PCR.
Values are normalised to HPRT expression and are shown relative to the
expression in untreated HDAC1
+/+ fibroblasts. Treatment as in Figure 2.
N=3;6 SD *p,0.05. (B) Aza-dC causes high level induction of VL30 and
IAP LTR element expression. N=3; 6 SD *p,0.05.
doi:10.1371/journal.pgen.1000927.g003
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Schematic view of a canonical VL30 retrotransposon. Two similar LTRs flank an internal region without functional open reading frame (upper part). Some
elements have a hybrid structure and are flanked by LTRs belonging to different subtypes (lower part). Primers used to amplify fragments of genomic and
transcribedVL30elementsfromuntreated,TSAandAza-dCtreatedfibroblastsareindicatedasblackarrows.(B)Tocharacterisethegenomic VL30 elements
identified as bona fide transcriptional sources, their 59LTR sequences were aligned (using the Megalign program with the following settings: Clustal W, gap
penalty 15, gap length penalty 6.66, delay divergent seqs 30%, DNA transition weight 0.5, DNA weight matrix IUB) and a phylogenetic tree was generated.
The LTR sequences fall intothree clades. The affiliation toone of the clades is determined by the structure of the highly polymorphic U3 region. While many
VL30 elements identified in untreated fibroblasts are associated with a subtype III U3 region, TSA and Aza-dC treatment leads to preferential expression of
elements with a type I U3 region. Coloured squares indicate the source, where the VL30 element has been isolated from (white, genomic DNA; black,
untreated fibroblasts; blue, TSA treated fibroblasts (166nM; 24h); red, Aza-dC treated fibroblasts (1mM; 24h; recover 24h), numbers indicate the
transcriptional activity of the respective elements (i.e. number of clones mapping best to this genomic locus). NVL3, BVL1, NVL1/2 serve as reference
elementswithknownU3regionsandaredescribedelsewhere[85–87].(C)TosurveythechromatinsignatureofindividualVL30elements,ChIPexperiments
in logarithmically growing fibroblasts untreated or treated for 12h with TSA (166nM) were performed. H3K4me3, H3ac and H4ac antibodies were used to
survey theenrichment of active histone marks, H3K9me2 and K3K27me3 antibodies to measure levels of repressive marks. Values were normalised to local
histone occupancy as determined with ChIP experiments using the c-H3 antibody and are given as percentage of Input. Primers targeting the upstream
regions and59LTRs of individual elements allowed determining histone modification levels of five specific VL30 elements. NT_039207 4840bp is an element
highly expressed upon TSAtreatment. NT_0396494919bp and NT_039341 4902bp are twoadditional elements found expressed in TSA treatedfibroblasts.
Those three elements are associated with a U3 subtype I LTR region. NT_039589 5224bp and NW_001030889 5248bp are equipped with subtype III and IV
U3 regions, respectively. N=2; 6 SD.
doi:10.1371/journal.pgen.1000927.g004
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with regulatory sequences important for transcriptional regulation.
Therefore, we determined the structure of the LTR regions
associated with expressed IAP and VL30 elements in more detail.
First, we analysed the LTRs associated with transcribed IAP
elements, which revealed a marked length polymorphism between
different LTRs: the shortest LTR, identified with an IAP element
expressed in untreated fibroblasts, comprised 322bp, whereas the
longest LTR, found in an IAP element expressed after Aza-dC
treatment, was 456bp long. Alignment of IAP LTR sequences
disclosed that this difference was due to the presence or absence of
nucleotides in a highly variable CT-dinucleotide-rich stretch
within the R region of the LTR (Table S1 and Figure S3B).
The region encoded a varying number of tandem repeat sequences
containing a 13bp core sequence (TCTCTCTTGCTTC), previ-
ously described as polymorphic marker for different IAP subtypes
[49]. Interestingly, the average length of this stretch was
significantly longer in LTRs associated with IAPs expressed upon
Aza-dC treatment (Figure S3C), indicating that upon loss of DNA
methylation an increased number of tandem repeats might be
favourable for expression.
As shown in earlier studies the structure of the VL30 LTR
region is crucial for stimulus mediated activation of VL30
expression (reviewed in [27]). Based on their highly divergent
U3 regions, VL30 LTRs have been classified into four distinct
subtypes: I, II, III and IV [50]. To allocate the VL30 elements
isolated in our transcript analysis to the four subtypes, we isolated
the 59LTR sequences from the genomic sequences, aligned them
together with VL30 LTR reference sequences (NVL3: subclass I,
BVL1: subclass III, NVL1/2: subclass IV) and generated a
phylogenetic tree. As depicted in Figure 4B, all elements including
the references were located in three distinct clades corresponding
to subclass I, III and IV elements. Elements expressed in untreated
cells mainly comprehend subtype III containing LTRs, which also
associate with most genomic elements (Figure 4B and Table S1).
As described above, transcripts arising upon TSA and Aza-dC
treatment, mainly originate from two types of loci: one VL30
insertion on chromosome 2 (NT_039207 4840bp) and several
other loci showing high similarity to another element on
chromosome 6 (NT_039341 4902bp). Interestingly, whereas the
VL30 element on chromosome 6 is flanked by LTRs containing
subtype I U3 regions at both ends, the element located on
chromosome 2 exhibits an unusual structural feature: it is
associated with two different LTRs, a 59 LTR containing a U3
region belonging to subtype I, but a 39 LTR containing a U3
region of subtype IV (Figure 4A, lower part). Transposon
transcription depends on the 59 LTR, therefore we conclude that
expression of this VL30 element is controlled by LTR sequences
comprising a subtype I U3 region. 40 out of 41 transcripts isolated
from TSA treated fibroblasts were associated with a LTR
containing a subtype I U3 region, suggesting that this LTR design
might be favourable for VL30 expression upon TSA treatment.
However, 36 of those 40 were derived from a single genomic
source. Therefore we wanted to clarify if increased VL30
transcription upon TSA treatment is exclusively caused by
activation of this particular locus mirroring a locus specific
phenomenon or if it reflects a general feature of subtype I
elements. We surveyed the chromatin signature at the 59LTRs of
five genomic VL30 elements via ChIP using flanking primers: the
highly responsive hybrid element on chromosome 2 (NT_039207
4840bp), two other subtype I elements (NT_039649 4919bp,
NT_039341 4902bp), one subtype III (NT039589 5225bp) and
one subtype IV element (MW_001030889 5248bp) (Figure 4C).
Interestingly, we detected increased levels of H3K4me3 (a mark
for active promoters) upon TSA treatment at all five VL30
elements, with the highest levels at the hybrid element, followed by
the two other subclass I elements (Figure 4C). The subclass III and
IV element showed the lowest response. A similar pattern could be
observed for H3ac and H4ac. In addition we monitored the
repressive histone mark H3K9me2, which was low in all elements
and remained unchanged upon TSA treatment. Another repres-
sive mark, H3K27me3 showed variable levels with no clear
correlation with VL30 subtypes. Together these data suggest an
increased responsiveness to activation of the hybrid element,
followed by other subclass I elements and finally subclass III and
IV elements.
Regulation of VL30 elements by a dual histone
modification mark
Based on the finding that VL30 elements respond to histone
acetylation, we examined the potential activation mechanism for
VL30 elements in detail. In the recent past VL30 elements have
been studied extensively and others showed that VL30 elements
expression is highly sensitive to a plethora of internal and external
stimuli [27,39,51]. Interestingly, many of those stimuli can be
described as internal or external stress in the broadest sense, and a
considerable number among them is able to trigger signalling
cascades such as the ERK or p38 pathways. Signalling via these
pathways ultimately leads to phosphorylation and activation of
several transcription factors but also to phosphorylation of
histone H3.
Phosphorylation of serine 10 at histone H3 (H3S10p) during
interphase is a rare event that correlates with the activation of
specific target genes [52,53]. Importantly, the presence of the
H3S10ph mark at promoter-associated chromatin coincides with
acetylation of neighbouring lysines K9 and K14 leading to a dual
histone modification termed phosphoacetylation [54–56]
(Figure 5A). Histone H3 phosphoacetylation correlates with the
activation of the so called ‘‘immediate early’’ genes c-fos and jun-
B, as well as late inducible genes such as HDAC1 [57].
The finding that the HDAC inhibitor TSA was sufficient to
highly induce VL30 expression in logarithmically growing
fibroblasts, where ERK pathways are activated through the action
of growth factors, prompted us to ask whether both stimuli, histone
acetylation and histone phosphorylation, were required for full
VL30 activation. To answer this question, we performed all
following experiments with serum-arrested Swiss 3T3 fibroblasts.
Serum withdrawal arrests cells in G0 and eliminates mitotic H3
phosphorylation, a modification that targets the majority of
histone H3 molecules during mitosis and is associated with
chromatin condensation. Furthermore, the absence of the serum-
dependent activity of different kinase pathways allows to selectively
activate specific signalling cascades, thereby triggering H3
phosphorylation. To induce the ERK pathway in fibroblasts, cells
were arrested in G0 for 72h and then treated with foetal calf serum
(FCS). Alternatively, anisomycin (Aniso) was used to activate the
p38 stress pathway. Additionally cells were treated with TSA to
induce hyperacetylation.
To analyse simultaneous phosphorylation and acetylation of
histone H3 we used an antibody that recognises histone H3 only in
the presence of the dual H3S10phK14ac mark (Figure 5A, Figure
S4). Figure 5B shows the effect of different compounds on histone
H4 acetylation and histone H3 phosphoacetylation in G0 arrested
Swiss 3T3 fibroblasts. As expected, TSA led to the accumulation
of hyperacetylated histones as detected by the H4ac antibody; H3
phosphoacetylation was low in untreated and TSA treated G0 cells
and slightly induced upon Aniso or FCS treatment. Combined
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phosphoacetylation of histone H3.
It was shown previously that, even upon Aniso/TSA stimula-
tion, the fraction of phosphoacetylated histone H3 is only minute
[52,58] and that the mark is localised to a restricted number of
genomic loci in Aniso/TSA treated fibroblasts (Simboeck E.,
unpublished results). Hence we tested, if phosphoacetylated
histones were associated with VL30 elements. To this end we
isolated chromatin from G0 arrested fibroblasts that were
untreated or treated with TSA, Aniso, or Aniso/TSA. We
performed ChIP experiments using the H3S10ph/H3K14ac
antibody or an unspecific control antibody and surveyed
phosphoacetylation levels of the VL30 59LTR regulatory region
via semi-quantitative PCR. Strikingly, we could detect phosphoa-
cetylated histones at VL30 elements at low levels when cells were
treated with Aniso alone, and at higher levels upon Aniso/TSA
treatment, but not in untreated or TSA-treated cells (Figure 5C).
Additional ChIP experiments with resting cells activated with
growth factors, containing serum in combination with TSA (FCS/
TSA), demonstrated the presence of phosphoacetylation also upon
Figure 5. VL30 expression correlates with the formation of a phosphoacetylation mark at chromatin associated with VL30 LTR
sequences. (A) Schematic view of a histone H3 tail carrying a so-called phosphoacetylation mark, i.e. concomitantly phosphorylated serine 10
(H3S10ph) and acetylated lysine 14 (H3K14ac). (B) Phosphoacetylation of histone H3 in response activation of the MAP kinase pathway and TSA
treatment in quiescent Swiss 3T3 fibroblasts. Serum deprived Swiss 3T3 fibroblasts were left untreated (arr) or treated for 2 hours with 166nM TSA,
189nM anisomycin (Aniso) or 20% v/v fetal calf serum (FCS) alone or combinations of anisomycin and TSA or FCS and TSA. Western blot analysis was
performed with antibodies directed against acetylated histone H4, H3S10pK14ac and an antibody against the C-terminus of histone H3 (c-H3) as
loading control. H3S10pK14ac The H3S10pK14ac signals were determined by densitometric scanning, normalised to c-H3 signals and are shown
relative to the value of untreated cells taken arbitrarily as 1. (C,D) The LTR region of VL30 elements is associated with histones carrying a
phosphoacetylation mark only upon MAP kinase pathway activation together with HDAC inhibition. ChIP experiments using an H3S10pK14ac specific
antibody reveals the presence of phosphoacetylated histones at VL30 LTR regions after anisomycin (189nM; 3h) or FCS (20%; 3h) and TSA (166nM; 3h)
treatment (Aniso + TSA; FCS + TSA). (E–G) Combinatorial treatment efficiently activates VL30 element expression in quiescent Swiss 3T3 fibroblasts.
Single treatment with TSA (166nM), FCS (20%) or anisomycin (189nM) (dark grey bars) leads to a modest induction compared to VL30 mRNA levels in
untreated cells (light grey bars). In contrast, combinatorial treatment with anisomycin or FCS and TSA robustly increases VL30 expression after 6h
(black bars). VL30 expression levels were determined with qRT-PCR; values are normalised to HPRT levels and given relative to VL30 levels in
untreated cells. N=3; 6 SD *p,0.05.
doi:10.1371/journal.pgen.1000927.g005
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hyperacetylation (Figure 5D). In summary, activation of the p38 or
ERK pathway together with induction of hyperacetylation
resulted in the establishment of a phosphoacetylation mark at
VL30 LTRs. In agreement with these findings we detected an
increased presence of the H3S10phK14ac mark at individual
VL30 insertions in TSA-treated proliferating HDAC1
+/+ fibro-
blasts suggesting a direct link between this dual histone
modification and transcriptional induction of particular VL30
elements (Figure S5).
Next, we examined the effect of the different stimuli on VL30
expression. We isolated RNA from arrested 3T3 Swiss fibroblasts
exposed to the aforementioned inducers, reversely transcribed
them and quantified VL30 levels with Real Time PCR. Whereas
single treatment of cells with TSA, Aniso, or FCS led to a modest
increase in expression, combined treatment with Aniso/TSA or
FCS/TSA resulted in robust induction, suggesting a synergistic
effect between histone phosphorylation via p38 or ERK activation
and histone acetylation (Figure 5E–5G). To directly test whether
activation of the ERK and p38 pathways is linked to H3
phosphoacetylation and VL30 activation, we took advantage of
the protein kinase inhibitor H89. This compound was used at a
concentration (10mM), shown to efficiently block histone H3
phosphorylation without affecting transcription factor phosphor-
ylation [53]. As presented in Figure 6A, inhibition of kinase
activity via H89 abolished the formation of a phosphoacetylation
mark upon Aniso/TSA treatment in arrested Swiss 3T3
fibroblasts. Equally important, H89 treatment also prevented
transcriptional induction upon Aniso/TSA treatment (Figure 6B),
indicating that H3S10p/H3K14ac does not only correlate with
transcriptional induction mediated by Aniso/TSA treatment, but
is necessary for proper VL30 expression.
Finally, we want to propose the following model for VL30
regulation, which integrates many of the previous findings about
VL30 induction: external stimuli activate the p38 (stress) or the
ERK (growth signal) pathway leading to activation of effector
kinases such as MSK1/2. By local phosphorylation of H3S10 at
responsive VL30 elements together with the induction of
hyperacetylation, a phosphoacetylation mark is established leading
to full transcriptional activation (Figure 7).
Discussion
It is well established that histone acetylation plays a fundamen-
tal role in the regulation of gene expression. This has been
demonstrated on a genome wide level as well as for numerous
individual genes [59–61]. The vast majority of work in mammals
has been dedicated to gene regulation in different cancer cells [62],
throughout development [6,63] or to the silencing of retroviruses
such as HIV [64,65]. Also the role of histone acetylation in the
reactivation of a silenced artificial transposon has been investigat-
ed [66], but to our knowledge no extensive study has been
performed so far to specifically analyse the interrelation between
histone acetylation and regulation of endogenous retroelements.
This is surprising, since chemicals targeting histone deacetylases
are considered as promising agents for the treatment of several
human diseases and possible effects on the expression of
endogenous retroelements remain largely unknown. Therefore
we aimed to define the role of histone acetylation on TE activity in
the mouse model system. We used an experimental system, in
Figure 6. Inhibition of H3S10 phosphorylation with the protein
kinase inhibitor H89 precludes transcriptional activation of
VL30 elements. (A) Treatment of arrested Swiss 3T3 fibroblasts with
the protein kinase inhibitor H89 (10mM), inhibiting H3S10 phosphory-
lation, prohibits the creation of a phosphoacetylation mark upon 1h of
Aniso+TSA treatment. ChiP experiments were performed as in Figure 5C.
(B) Precluding phosphoacetylation of VL30 elements with H89 also
abolishes transcriptional induction upon Aniso + TSA treatment.
Treatments as in (A); quantification of VL30 transcript levels were
determined as in Figure 5E. N=3; 6 SD *p,0.05.
doi:10.1371/journal.pgen.1000927.g006
Figure 7. Model of VL30 element activation. Full transcriptional
activation of VL30 elements is triggered by a dual histone modification
mark, i.e. phosphoacetylation of histone H3 at serine 10 and lysine 14.
Phosphorylation of serine 10 (green circle) is conveyed by activation of
the p38 stress (e.g. via anisomycin (Aniso)) or the ERK growth factor
inducible MAPK pathway (e.g. via serum (FCS)) ultimately leading to the
activation of the MSK1/2 kinase and H3S10 phosphorylation. Histone
hyperacetylation (red circle) can be induced by HDAC inhibition (e.g. via
TSA). Combined treatment results in the formation of phosphoacety-
lated histones at VL30 LTRs and full transcriptional activation.
doi:10.1371/journal.pgen.1000927.g007
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hyperacetylated state. This was achieved using the broad HDAC
inhibitor TSA. Depletion of the major histone deacetylase
HDAC1 was not sufficient to induce global hyperacetylation.
Interestingly, incubation of cells with the DNMT inhibitor Aza-dC
also resulted in increased histone acetylation levels, once more
underscoring the close link between DNA methylation and histone
acetylation [7]. However, this relation seems to be asymmetric,
since the maintenance of DNA methylation did not require
normal histone acetylation levels.
TE expression and histone acetylation
Having monitored global changes mediated by TSA and Aza-dC
treatment, we focused our interest on the interrelation between
histone acetylation and TE regulation. We determined histone
acetylationlevelsofarepresentativeselectionofTEsinHDAC1
2/2
background, upon TSA and Aza-dC treatment. Subsequently, we
correlated these data with the expression levels of the corre-
sponding TEs. This analysis revealed the following key findings:
(1) only three out of eleven TEs tested were significantly activated
by Aza-dC treatment. Inhibition of DNA methyltransferases in
fibroblasts strongly enhanced the expression of IAP, VL30 and
MuLV LTR elements. These data indicate that a block in DNA
methylation was sufficient to activate transcription of some, but
not all TEs in fibroblasts. Efficient transcriptional activation of
other TEs might depend on activating cofactors absent in
fibroblasts. This is consistent with the finding that many TEs
exhibit tissue- or cell type-specific expression patterns [67–69].
Alternatively, additional layers of silencing mechanisms directed
against specific TE families could be present in fibroblasts in the
absence of DNA methylation.
(2) Enhanced expression roughly correlated with increased
acetylation. This was obvious for VL30 elements, which were
highly expressed upon TSA and Aza-dC treatment, and for IAP
elements, which were induced after treatment with Aza-dC: both
LTR elements exhibited hyperacetylation when activated. Re-
markably, loss of DNA methylation at IAP elements was
accompanied by increased acetylation, whereas HDAC inhibition
by TSA did not result in IAP-associated histone hyperacetylation.
This suggests a model, in which histone acetyltransferase (HAT)
activity is tethered to IAPs only upon loss of DNA methylation,
which otherwise might prohibit the binding of transcription factors
recruiting HATs. Hence, HDAC inhibition in cells with intact
DNA methylation was not sufficient to induce local hyperacetyla-
tion. The situation of VL30 element regulation was strikingly
different. Inhibition of HDAC activity led to robust hyperacetyla-
tion, pointing towards a direct involvement of HDACs and HATs
in the transcriptional control of VL30 elements. Finally, we
observed that SINE elements gained hyperacetylation upon Aza-
dC and TSA treatment, which was accompanied with mild effects
on transcription. However, SINEs posses some peculiar features,
making them distinct from other TEs: they are short, highly
repetitive sequences, which tend to accumulate nearby and within
genes and their regulatory regions. Therefore, it is difficult to
unambiguously assign the increase in histone acetylation and RNA
abundance to direct activation of SINE elements and not to the
activation of Aza-dC- or TSA-responsive target genes containing
SINE element sequences.
(3) TSA treatment led to hyperacetylation of histone H4
independent of transcriptional activity. Histone H4 specific HATs
seemed to readily acetylate lysine residues of H4 when the
dominant HDACs were inhibited, suggesting their regular
presence at silent TEs. In contrast, acetylation of histone H3
seemed coupled with transcription, pointing towards a model, in
which histone H3 acetylation might stimulate the recruitment of
the transcription machinery. Alternatively, histone H3 specific
HATs were recruited together with the transcription machinery.
Interestingly, Koch and colleagues recently showed that although
H4ac and H3ac were both enriched around the transcriptional
start site, only H3ac could be used as a highly predictive marker
for gene activity [60]. One might speculate that differential HAT
recruitment reflects a functional difference between histone H3
and histone H4 acetylation. In addition to their role in
transcription where both modifications act synergistically, H4
(de)acetylation could have other biological functions not described
so far.
Preferential expression of defined TE subfamilies
Examining IAP and VL30 transcripts in untreated fibroblasts
clearly showed that expressed TEs originate from multiple loci
dispersed throughout the genome. However, upon treatment with
different stimuli, certain transposon subfamilies were preferentially
expressed. We could show that these inducible elements harboured
characteristic DNA sequence features within the LTR, the
regulatory region of the element. IAPs were more efficiently
activated by Aza-dC, when they carried increasing numbers of
DNA sequence repeats, containing putative binding sites for the
transcription factor CCAAT/enhancer-binding protein alpha (C/
EBPa) (identified with the Alibaba2.1 transcription factor binding
site program using the TRANSFAC 4.0 database). Strikingly,
Ishihara and colleagues, who characterised IAP elements active
upon irradiation of mouse acute myeloid leukaemia (AML) cells,
isolated IAP elements with especially long stretches of C/EBPa
binding sites [70] (Table S1, AB099818). In contrast, IAP elements
responsible for recent integration events in the mouse germline
[12] harboured only one TF binding site (Table S1, X04120 and
AxinFu). Therefore, the availability of the transcription factor
might influence the choice of which IAP subtypes are expressed in
different cellular contexts.
Treatment with TSA or Aza-dC led to preferential expression of
one particular VL30 element associated with a U3 subtype I LTR.
This individual element also showed particularly high levels of
active histone marks (H3K4me3, H3ac, H4ac, H3S10phK14ac)
upon TSA treatment. Other elements driven by a subtype I LTR
giving rise to transcripts showed intermediate enrichment levels,
whereas the analysed subclass III and IV elements, which were
hardly expressed under these conditions, exhibited lowest levels of
active chromatin marks. Nilsson and Bohm earlier proposed a
model stating that the enhancer design of VL30 elements
determines tissue specific expression and the response to external
stimuli [50]. Our data support this model. Subtype I U3 promoters
seem to be specifically susceptible to activation in this cell type.
This could also be observed in arrested Swiss 3T3 fibroblasts.
When treated with Anisomycin and TSA, 5 out of 14 (36%)
transcripts were derived from an element with a subtype I U3
region; when left untreated we could only detect transcripts
derived from subtype III elements (7 out of 7) (Table S1).
Nevertheless, it remains unclear, which features distinguish the
highly expressed hybrid element from other VL30 elements.
Examination of the genomic environment did not reveal any
obviously unusual architecture, the closest protein coding genes
being located 764kb upstream and 16kb downstream of the
element.
VL30—an unusual type of retrotransposon
Our finding that VL30 elements could be reactivated with Aza-
dC was in accordance with DNA methylation as the dominant
silencing mechanism for TEs and supported by previous reports
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that a multitude of other stimuli without link to DNA methylation
was able to trigger VL30 expression [27,39,51,71]. Therefore,
DNA methylation might be only one of several independent
silencing pathways. Alternatively, Aza-dC treatment could be the
cause for indirect effects leading to VL30 upregulation indepen-
dent of DNA methylation levels at VL30 elements. Interestingly,
loss of Dnmt1 in mouse brain tissue is not sufficient to influence
VL30 expression (S.L. and C.S., unpublished data), although other
stimuli have been reported to efficiently trigger VL30 in neurons
[71]. This observation supports a model that Aza-dC might be an
indirect trigger for VL30 activation.
Other mammalian TEs also respond to external signals, e.g. SINE
elements can be reactivated via stress as well as Adenovirus infection
[24,25], LINEs by benzo(a) pyrene [26]. In cancer cells, TE silencing
is impaired probably due to altered DNA methylation patterns
[72,73], and several human diseases are associated with a relaxation
of TE repression [74]. Nonetheless, the regulation of VL30
expression is unusual among mammalian retrotransposons; a diverse
repertoire of stimuli is able to highly induce transcription in several
cell systems such as fibroblasts, keratinocytes, haematopoietic, and
neuronal cells [27,39,51]. In contrast to many other TEs, VL30
elements seem to exist in a default state, which is ‘‘poised for
transcription’’, without stringent silencing mechanisms. External
stimuli can easily flip the switch to ‘‘active transcription’’. There are
several feasible explanations for this exceptional situation: (1) it may
mirror the unusual life cycle of VL30 elements. They can be packed
into MuLV (murine leukaemia virus) viral particles and get
horizontally transferred, rather than vertically propagated as
endogenous parasites [27]. For such a life cycle it is essential to be
efficiently transcribed in somatic cells. Of special benefit could be a
system that allows the elements to ‘‘sense’’ the physiological situation
of the host. Stressful conditions might trigger high-level transcription
and increase the chance to escape the host successfully via virus-
mediated horizontal exit strategies. (2) Song and colleagues recently
showed that VL30 RNA can interact with the DNA-binding protein
PSF and modulate PSF-mediated repression of target genes [75,76].
Therefore, VL30 elements could have acquired physiological
functions in murine cells and might be necessary for the regulation
of certain host genes (a process, called molecular domestication [77]).
VL30 expression is synergistically regulated by histone
acetylation and phosphorylation
Another novel finding of our study is the positive impact of histone
H3 phosphoacetylation on VL30 transcription. For several years,
mechanistic links between histone acetylation and histone phosphor-
ylation caused by different stimuli, including stress and growth
factors, have been known. For example, immediate early genes such
as c-myc, c-fos, c-jun, TFF1 [54–56,78], but also others [57], depend
on the induction of histone H3 phosphoacetylation.
In a series of experiments we could show that VL30 expression was
synergistically activated by stimuli leading to histone phosphorylation
(FCS, anisomycin) and histone acetylation (TSA); full transcriptional
activity was correlated with the formation of phosphoacetylated
histone proteins at the VL30 LTR. Inhibition of the nucleosomal
responsebyH89abolishedVL30phosphoacetylationandexpression,
indicating that the formation of this dual histone mark was necessary
for activation caused by FCS/TSA or anisomycin/TSA and that
MSK1/2 might be the responsible kinase responsible for phosphor-
ylation. In summary, we collected data supporting a model that VL30
transposable elements are novel phosphoacetylation target genes. Still
many details about the exact mechanism of VL30 regulation via dual
histone modification are unclear, and it remains to be determined
which are the responsible HAT(s), HDAC(s) and phosphatase(s)
regulatingdynamicacetylationandphosphorylation.Inthiscontextit
will be interesting to investigate putative connections between
enhancer design, transcription factor binding, and recruitment of
histone modifiers dependent on the VL30 subtype.
Transposition rates of several TEs are not influenced by
HDAC inhibition
The link between TE transcription and transposition is
fundamental. Production of an adequate amount of mRNA is an
essential premise for all subsequent steps in the lifecycle of a TE.
Having monitored the influence of HDAC inhibition on
transcription of several TEs, we also examined, if there is an
influence on subsequent events resulting in altered transposition
activity. We used an experimental system, which allowed us to
survey transposition rates of episomally delivered LTR and LINE
elements upon HDAC inhibition. We detected only minor
differences in the frequency of retrotransposition events when
cells were treated with TSA, i.e. transposition events were slightly
increased upon TSA treatment. We also observed a comparable
enrichment of the transcript. Therefore, we could not detect
obvious effects on transposon activity exceeding effects coherent
with enhanced transcription. Final answers on the issue of histone-
and protein-acetylation, influencing the process of transposition in
mammals, will certainly demand further and more detailed
investigations.
Implications for HDAC inhibitor treatment of humans
HDAC inhibitors are promising anticancer drugs because they
can change gene expression patterns in cancer cells, leading to cell
cycle arrest or apoptosis [4]. More recently, their use for the
treatment of non-cancer diseases has also been suggested [79,80].
Our finding that HDAC inhibition can reactivate VL30 elements
in mice might indicate that other TEs or non-coding elements
could also respond to an epigenetic therapy in humans. Therefore,
careful evaluation of potential effects beyond the deregulation of
single copy genes will be an important issue for future studies. An
interesting aspect – along with other dangers arising from
increased TE activity – will be their emerging potential to
modulate cellular regulatory networks. An exiting example for
such a pathway conserved in mice and humans is the interaction of
the PSF protein and VL30 RNA in mice and other non-coding
TE-derived RNAs in human cells, respectively, affecting tumour-
igenesis [81].
Materials and Methods
Cell lines
Wildtype (HDAC1
+/+) and corresponding HDAC1
2/2 fibro-
blasts cell lines were established from E13.5 embryos carrying two
floxed alleles of the Hdac1 gene [82]. Primary fibroblasts (mixed
129SvOla/Bl6, more than 80% being of Bl6 origin) were isolated
and immortalised following the 3T3 immortalisation protocol
[83]. Subclones were either transfected with a control vector or a
vector encoding the cre recombinase leading to the deletion of
exon 6 encoding the catalytic core of HDAC1. Cells were
maintained in DMEM supplemented with 10% foetal calf serum
(FCS) and gentamycin. For growth arrest of cells, Swiss 3T3
fibroblasts were serum starved for 72h in DMEM containing 0.2%
FCS.
Inhibitor treatments
The following inhibitors were used in this study: trichostatin A
(TSA) (50 ng/ml [166 nM]; Wako Pure Chemical Industries) was
applied for 3–24h; 59Aza-29-deoxycytidine (Aza-dC) (1mM) for 24h
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inhibitor; anisomycin (Aniso) (50 ng/ml [189 nM]; Sigma) for 1–
6h, and H89 (10 mM; Alexis Biochemicals) for 1h 15min. H89 was
added 15min prior to anisomycin.
Transposition assay
Plasmids carrying a tagged IAP, MusD, L1.Md or L1.Hs
retrotransposon (described in [48]) were transfected into logarith-
mically growing U2OS cells maintained in DMEM with 10% FCS
and gentamycin. Cells were split 24h prior to the transfection
procedure and 1610
5 cells were seeded on a 6-well plate.
Transfection was performed with 1mg of plasmid DNA and
Lipofectamine (Invitrogen) following the manufacturer’s instruc-
tions. After 6h, the medium was replaced by DMEM supple-
mented with 10% FCS and gentamycin. If required, 66nM TSA
was added for 24h after transfection. To monitor expression levels
of the transfected constructs, cells were lysed 24h post transfection
with TRIzol reagent (Invitrogen), RNA was isolated, DNase
treated, reversely transcribed and subjected to quantitative RT-
PCR as described above. The following primers were used for
normalisation: GAPDH-for TCT TCT TTT GCG TCG CCA G,
GAPDH-rev AGC CCC AGC CTT CTC CA and determination
of episomal TE expression: Neo-for ATC AGA CAG CCG ATT
GTC TG, Neo-rev CAG TTC CGC CCA TTC TCC G. For the
analysis of transposition rates, cells were transferred to a 10cm dish
24h post transfection and cultured for 1 week, split and reseeded
on 10cm dishes (5610
5 per dish). Selection for neo-positive cells
was started 24h later by adding 500mg/ml G418 to the growth
medium. After 2 weeks, cell clones were fixed with 70% EtOH,
stained with 0.1% methylene blue/0.5M Na-acetate solution and
counted.
Western blot and dot blot analysis
Histone and total protein preparation for Western blot analysis
was performed as previously described [57]. The following
antibodies were used: HDAC1 polyclonal antibody (Millipore
06-720), HDAC2 3F3 monoclonal antibody (Millipore 05-814),
HDAC3 (Abcam ab16047), DNMT1 (Abcam ab13537), b-actin
(Sigma A5316), H3ac (Millipore 06-599), H4ac (Millipore 06-598),
H3K4me3 (Millipore 07-473), H3S10pK14ac (Millipore 07-081
and a rabbit serum raised against the H3 peptide ARTKQ-
TARKS(ph)TGGK(ac)APRKQL in collaboration with Eurogen-
tec, Belgium) and c-H3 (Abcam ab1791). Densitometric quanti-
fication of Western blots was performed with the Imagequant
software. For Dot blot analysis, 1 microliter of each peptide
(0.2 mg/ml and 0.04 mg/ml in water) was spotted on a PVDF
membrane, antibody incubation and detection was performed by
standard Western blot methods.
DNA methylation analysis
To quantify DNA methylation levels at defined DNA sequences,
we employed the MS-SNuPE technique as described elsewhere
[32]. Primers for PCR: bs-IAP-rc-for GTT TTA GTA TAG
GGG AAT GTT AGG GTT; bs-IAP-rc-rev ACC AAA AAA
AAC ACC ACA AAC CAA AAT CTT CTA C. Primers for the
SnuPE reaction: rcS789 GTA GTT AAT TAA GGA GTG ATA;
rcS628 AGA TTT TTG TGT TGG GAG T; rcS894 GAA GAT
GTA AGA ATA AAG TTT TGT.
Chromatin immunoprecipitation assay
Preparation of soluble chromatin and chromatin immunopre-
cipitation assays were carried out as described previously [57].
Antibodies for immunoprecipitation of modified histones were
obtained from Millipore (H3ac 06-599, H4ac 06-598, H3S10p/
H3K14ac 07-081) or generated in collaboration with Eurogentec,
Belgium (H3S10p/H3K14ac), the antibody recognising C-termi-
nal histone H3 was ordered from Abcam (c-H3 ab1791).
H3K9me2 and H3K27me3 antibodies were a kind gift of T.
Jenuwein, MPI Freiburg. As negative control unspecific IgGs from
preimmunsera were used. Quantification of precipitated material
was performed via quantitative Real-Time PCR employing an
iCycler iQ system from Bio-Rad, SYBER-green (Molecular
probes) and Taq DNA Polymerase (Fermentas) or via semi-
quantitative PCR using a Biometra T3 thermocycler and the
GoTaq PCR Master mix from Promega followed by visualisation
of DNA fragments on an ethidium bromide stained 2% agarose-
TAE gel. Primers have been described elsewhere [15,84] or can be
found in Table S2.
Expression analyses
RNA was extracted with TRIzol Reagent (Invitrogen), possible
genomic DNA contamination was removed using Turbo DNase
(Ambion) and cDNA was synthesised with the iScript cDNA
Synthesis Kit (Bio-Rad). For quantification of transcripts we
performed RT-PCR on an iCycler iQ system from Bio-Rad using
SYBER-green (Molecular probes) and Taq DNA Polymerase
(Fermentas). Primers sequences have been described previously
[15,84] and are given in Table S2.
Cloning of genomic and expressed transposable
elements
To characterise TE transcripts, RNAs from three independent
biological samples from untreated, TSA and Aza-dC treated
fibroblasts were harvested, extracted with TRIzol Reagent
(Invitrogen), DNase treated (Turbo DNase, Ambion), reversely
transcribed (iScript, Bio-Rad) and used for PCR amplification in
doublets (Biometra T3 thermocycler, GoTaq PCR Master mix
from Promega; primers see Table S2). As control, PCR reactions
were also performed with genomic DNA as template, amplifying
genomic elements. The resulting six PCR reactions for each
condition were pooled (to exclude a bias due to PCR reactions),
loaded on an ethidium bromide stained agarose-TAE gel, eluted
and purified using the Wizard Plus SV Gel and PCR Clean Up
System (Promega). DNA fragments were cloned into the pGEM-T
vector system (Promega) and transformed into E.coli (DH5a).
Positive clones were grown in LB liquid medium, plasmid DNA
was extracted using the Wizard Plus SV Miniprep DNA
Purification System (Promega) and sequenced.
Supporting Information
Figure S1 MuLV LTR element expression. mRNA was isolated
from logarithmically growing wildtype fibroblasts (HDAC1
+/+)o r
HDAC1 deficient fibroblasts (HDAC1
2/2) and from wildtype
fibroblasts treated with TSA (166nM; 24h) or Aza-dC (1mM; 24h,
24h recovery). Expression levels were determined with qRT-PCR.
Values are normalised to HPRT expression and are shown relative
to the expression in untreated HDAC1
+/+ fibroblasts. N=3; 6
SD.
Found at: doi:10.1371/journal.pgen.1000927.s001 (0.12 MB TIF)
Figure S2 TSA treatment has only minor impact on the
transposition frequency of retrotransposons. (A) Representation
of a retroelement marked with a neo reporter gene. The
retroelement carries its set of functional genes, allowing autono-
mous retrotransposition and a neo cassette which is placed in
reverse orientation, interrupted by an intron framed by a splice
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activate the expression of the neo gene from its promoter (Pr),
retrotransposition including the steps of transcription, splicing,
reverse transcription and integration, has to occur. (B) Experi-
mental procedure to detect retrotransposition rates and expression
levels of the tagged element. After transfection, cells were treated
with 66nM TSA for 24h to determine the effect of HDAC
inhibition on transposition frequency determined by quantification
of G418 resistant clones. To monitor the influence of HDAC
inhibition on expression, mRNA abundance was measured via
Real Time PCR. Primers were designed for the neo gene cassette
and values were normalised against levels of the housekeeping
gene GAPDH. (C) Analysis of the activity of murine LTR elements
MusD and IAP, the murine non-LTR element L1.Md and the
human non-LTR element L1.2B in U2OS cells upon TSA
treatment. Transposition events were determined by counting
G418 resistant clones fixed with EtOH and stained with methylene
blue. The numbers of clones in TSA treated cells are given relative
to the numbers of clones in untreated cells (Transposition rate).
Expression of tagged retrotransposons was determined measuring
the abundance of neo mRNA (Expression). Values for mRNA
levels upon TSA treatment are given in percentage based on the
mRNA levels determined in untreated cells. Values represent
mean values of at least three independent experiments. 6 SD.
Found at: doi:10.1371/journal.pgen.1000927.s002 (1.10 MB TIF)
Figure S3 Characterisation of transcribed IAP elements reveals
preferential expression of defined IAP subtypes upon stimulation.
(A) Schematic view of a full length IAP retrotransposon. Three
partly overlapping open reading frames encoding the gag, prt and
pol genes are flanked by long terminal repeats (LTRs). The LTRs
are comprised of a U3 region, followed by the R and U5 region.
Primers used to amplify fragments of genomic and transcribed IAP
elements from untreated, TSA and Aza-dC treated cells are
indicated as black arrows. (B) Partial alignment of IAP R regions
shows that the CT-rich region consists of a variable number of
tandem repeat sequence motifs. This TCTCTCTTGCTTC core
motif contains a binding site for the transcription factor CCAAT/
enhancer-binding protein alpha (C/EBPa). The selected sequenc-
es were derived from public databases and correspond to
previously described IAP elements (M17751; AC012382;
AB99818) or sequences obtained during the analysis of expressed
IAP elements in fibroblasts (G 06; T 18; A 22). (C) The length of a
highly polymorphic CT-rich stretch within the R region of IAP
elements is increased in IAP elements expressed upon Aza-dC
treatment. Number of R regions investigated per condition:
genomic: N=27; untreated: N=26; TSA: N=31; Aza-dC:
N=30.
Found at: doi:10.1371/journal.pgen.1000927.s003 (0.48 MB TIF)
Figure S4 Characterisation of the antibody directed against
histone H3 concomitantly phosphorylated at serine 10 (H3S10p)
and acetylated at lysine 14 (H3K14ac). 40 and 200 ng of each
peptide corresponding to aa 1–20 of histone H3 unmodified or
with the indicated modifications were spotted on a PVDF
membrane and probed with the H3KS10ph14ac antiserum. In
parallel, 1000 ng of each peptide from the same dilution
series were spotted on a duplicate membrane and stained with
Ponceau S.
Found at: doi:10.1371/journal.pgen.1000927.s004 (0.84 MB TIF)
Figure S5 H3 phosphoacetylation marks VL30 elements in 3T3
fibroblasts. H3S10phK14ac levels at defined genomic VL30
elements in logarithmically growing fibroblasts untreated or
treated with TSA (12h; 166nM) was determined via ChIP as
described in Figure 4C.
Found at: doi:10.1371/journal.pgen.1000927.s005 (0.28 MB TIF)
Table S1 Characterisation of cloned IAP and VL30 elements
Sheet IAP: Characteristic features of cloned IAP elements. Clones
G 01 to G 27 correspond to IAP elements amplified from genomic
material, 0 01 to 0 26 to IAP elements expressed in untreated cells,
T 01 to 31 and A 01 to 30 to IAPs expressed upon TSA or Aza-dC
treatment, respectively. Given is the identity of the cloned
sequence to the closest related genomic sequence (Identity), the
corresponding genomic contig (Contig), the chromosomal coordi-
nates (Chrom. Coordinates) on the mm9 genome assembly (July
2007), chromosome number (Chromosome), length of the genomic
IAP element (bp), and affiliation to one of the three subgroups: full
length, ID1 deletion type or IAP carrying another deletion (Type).
Finally, the LTR is characterised in terms of length (bp), length of
the CT-rich hypervariable region in the R region (CT bp) and
identity of the 59 LTR to the 39LTR (Identity). The list is further
extended by the characterisation of eight IAP elements published
earlier (M17551, AB099818, AC012382, AC087891, AC090431,
AL590616, X04120, AxinFu). Sheet VL30: Characteristic features
of cloned VL30 elements. The first column indicates, the template
for DNA amplification (G) genomic DNA, (0) cDNA from
untreated fibroblasts, (T) cDNA from TSA treated fibroblasts,
(A) cDNA from Aza-dC treated fibroblasts, (AT) cDNA from
Anisomycin+TSA treated fibroblasts. Given is the identity of the
cloned sequence to the most similar genomic sequence (Identity),
the corresponding genomic contig (Contig), the chromosomal
coordinates (Chrom. Coordinates) on the mm9 genome assembly
(July 2007), chromosome number (Chromosome) and length of the
genomic VL30 element (bp). The LTR is characterised in terms of
length (bp), identity between 59 LTR and 39LTR (Identity) and the
affiliation of the U3 region to one of the four described subgroups
(I–IV).
Found at: doi:10.1371/journal.pgen.1000927.s006 (0.06 MB
XLS)
Table S2 List of TE-specific primers used in this work. Given
are primer sequences used for quantification of ChIP experiments,
expression analyses and cloning of TE derived transcripts. The
numbers underneath the DNA sequences indicate how many TE
copies of each family are expected to be amplified with the primers
chosen. In silico analyses for testing primer specificities and
estimating TE copy numbers were performed via NCBI Primer-
Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.
cgi?LINK_LOC=BlastHome) by searching candidate TE primer
sets against the Mus musculus genome database (taxid: 10090)
under high stringency primer conditions, i.e., allowing not more
than one mismatch per primer. Only hits of expected fragment
size were counted as individual TE copies along the mouse
chromosomes.
Found at: doi:10.1371/journal.pgen.1000927.s007 (0.02 MB
XLS)
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